F-group (family)
5001.1.1.5 7tm_3
Ligands and drugs
677
Member domains
128
with ligand contacts (≤ 4 Å)
18.9% of members
79
with DrugDomain annotations
11.7% of members
57
with a DrugBank compound
8.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5001.1.1.5 belongs to X-group 5001 Family A G protein-coupled receptor-like, which binds 10.2 ligand superclasses per 20 proteins, broader than 95% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04540 | CLR | Cholesterol | 28 |
| DB05695 | YP1 | NPS-2143 | 8 |
| DB01012 | YP4 | Cinacalcet | 6 |
| DB00142 | — | Glutamic acid | 5 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 4 |
| DB12388 | H43 | Evocalcet | 4 |
| DB12059 | HZR | JNJ-40411813 | 3 |
| DB04327 | PEE | Phosphatidylethanolamine | 2 |
| DB00127 | — | Spermine | 1 |
| DB00168 | — | Aspartame | 1 |
| DB00659 | — | — | 1 |
| DB02772 | — | — | 1 |
| DB04256 | — | (S)-alpha-methyl-4-carboxyphenylglycine | 1 |
| DB05255 | — | — | 1 |
| DB06201 | — | — | 1 |
| DB11093 | — | — | 1 |
| DB11348 | — | — | 1 |
| DB12733 | — | — | 1 |
| DB12865 | — | — | 1 |
| DB12931 | D7W | Fenobam | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CLR | CHOLESTEROL | 48 |
| 9IG | 3-(2-chlorophenyl)-N-[(1R)-1-(3-methoxyphenyl)ethyl]propan-1-amine | 12 |
| A1LYA | [(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-octadecanoyloxy-propyl] 2-(trimethylazaniumyl)ethyl phosphate | 12 |
| YP4 | N-[(1R)-1-(naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine | 12 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 10 |
| OLA | OLEIC ACID | 8 |
| YP1 | 2-chloro-6-[(2R)-2-hydroxy-3-{[2-methyl-1-(naphthalen-2-yl)propan-2-yl]amino}propoxy]benzonitrile | 8 |
| A1AF7 | (19R,22S,25R)-22,25,26-trihydroxy-16,22-dioxo-17,21,23-trioxa-22lambda~5~-phosphahexacosan-19-yl (9Z)-octadec-9-enoate | 6 |
| FN0 | (3S)-5,7-ditert-butyl-3-oxidanyl-3-(trifluoromethyl)-1-benzofuran-2-one | 6 |
| PCW | 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 6 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 6 |
| XQT | VU0424465 | 6 |
| AV0 | Lauryl Maltose Neopentyl Glycol | 4 |
| EIJ | (2S)-1-{[(S)-hydroxy{[(1s,2R,3R,4R,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate | 4 |
| H43 | 2-[4-[(3S)-3-[[(1R)-1-naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]ethanoic acid | 4 |
| L9Q | (1S)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate | 4 |
| MW9 | (21R,24R,27S)-24,27,28-trihydroxy-18,24-dioxo-19,23,25-trioxa-24lambda~5~-phosphaoctacosan-21-yl (9Z)-octadec-9-enoate | 4 |
| PEF | DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE | 4 |
| SPM | SPERMINE | 4 |
| HZR | 1-butyl-3-chloranyl-4-(4-phenylpiperidin-1-yl)pyridin-2-one | 3 |